Armistice Capital’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,517
Closed -$54.1K 312
2024
Q2
$54.1K Buy
1,517
+817
+117% +$29.2K ﹤0.01% 233
2024
Q1
$44.4K Sell
700
-33
-5% -$2.09K ﹤0.01% 311
2023
Q4
$57.2K Sell
733
-1,142
-61% -$89.1K ﹤0.01% 258
2023
Q3
$148K Buy
1,875
+961
+105% +$75.9K ﹤0.01% 207
2023
Q2
$163K Buy
+914
New +$163K ﹤0.01% 180